Revista de farmácia e bioquímica da Universidade de São Paulo, Volumes 29-32Faculdade de Ciências Farmacêuticas da Universidade de São Paulo., 1993 |
From inside the book
Results 1-3 of 33
Page 5
... compounds are now being tested in clini- cal phases . Table 1 shows the number of compounds under research and development in 1981-1986104 . It can be noticed that the Table 1. Compounds under research and development by thera- peutic ...
... compounds are now being tested in clini- cal phases . Table 1 shows the number of compounds under research and development in 1981-1986104 . It can be noticed that the Table 1. Compounds under research and development by thera- peutic ...
Page 10
... compounds 49,52 . However , it is in the infancy yet , the need of deep knowledge about the mo- lecular aspects of diseases being the main reason for the few number of drugs introduced by this method . The discovery of a specific ...
... compounds 49,52 . However , it is in the infancy yet , the need of deep knowledge about the mo- lecular aspects of diseases being the main reason for the few number of drugs introduced by this method . The discovery of a specific ...
Page 73
... compounds In the proton magnetic resonance spectra can be observed17 : in the AM , compound a singlet signal at 8 2.0 - 1.9 that can be attributted to the protons of the methyl group ( c ) . In the AM , compound , it is possible to ...
... compounds In the proton magnetic resonance spectra can be observed17 : in the AM , compound a singlet signal at 8 2.0 - 1.9 that can be attributted to the protons of the methyl group ( c ) . In the AM , compound , it is possible to ...
Contents
Trabalho de RevisãoReviews | 1 |
Trabalhos originaisOriginal papers | 11 |
LEILIANE COELHO ANDRÉ AMORIM EDNA MARIA ALVAREZLEITE Determinação de ortocresol 1520 | 15 |
42 other sections not shown